The purpose of this article is to highlight the nuclear program target struck in Iran by Israel on 26 October 2024. Public reporting has not counted this target as a “nuclear program target.” But the history of the facility is connected solely to the Iranian nuclear weapons program, and there is good reason to believe it continues to be. The fact that Israel found it worth attacking in a limited strike is a strong indication of that – whatever its current state of activity.
‘Historic’: Federal Court Says AstraZeneca Not Immune From Liability in Case Involving Woman Injured by COVID Vaccine During Clinical Trial
Peloni: Congratulations to Brianne Dressen! Her steadfast pursuit of justice in this matter has laid an important path for others to pursue just compensation after being injured during the drug trials testing. Of course, this victory has been achieved in spite of the PREP Act liability protections rather than overturning them, but it remains as an important victory, nonetheless. The PREP Act needs to be overturned, and those who have been injured must be awarded the care, support and clear recognition of their injuries. It is impossible to believe how many have been abandoned to such a fate of incapacitation due to this single piece of legislation.
Federal Judge Robert J. Shelby said the PREP Act’s liability shield does not extend to breach-of-contract claims. He said the basis of Brianne Dressen’s claim “is a broken promise, not a countermeasure.”
- This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.
A federal court ruled Monday that a lawsuit filed by a woman injured by AstraZeneca’s COVID-19 vaccine during a U.S. clinical trial can continue. The court rejected the drugmaker’s claim that a federal liability shield protects it from breach-of-contract claims.
Brianne Dressen sued AstraZeneca in May, alleging she was injured and became disabled by the company’s vaccine in 2020 when she participated in the company’s clinical trial.
